Skip to main content

Diverting a Diet Drug

Diverting a Diet Drug How did a controversial product become the first weight-loss drug to be available without a prescription? By Fran Hawthorne Illustrations by Bill Sanderson Related Articles 1 "That was another big Aha! moment, because we didn't know that study existed," Burton says. The researchers found that people who took orlistat (the generic name for Xenical) experienced a 37% lower risk of type 2 diabetes. According to the report, "the overal

Written byBill Sanderson
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00

By Fran Hawthorne
Illustrations by Bill Sanderson

1 "That was another big Aha! moment, because we didn't know that study existed," Burton says.

The researchers found that people who took orlistat (the generic name for Xenical) experienced a 37% lower risk of type 2 diabetes. According to the report, "the overall incidence of adverse events was similar" in the control group and the group on orlistat, although more people on orlistat experienced "mild to moderate" gastrointestinal events. (The incidence decreased as people stayed longer on the drug.) Along with the more common side effects, Xenical can interfere with the absorption of many drugs such as warfarin and cyclosporine, as well as fat-soluble vitamins. Rarely, it's been linked to acute kidney injury and liver problems. 2

The GSK team left the Marriott meeting eager to move ahead. But the ball was in Roche's court. And Roche wasn't sure it wanted to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo